EUVIMEDEUVIMED entdecken
Leserbrief

Polyploid giant cancer cells: Unveiling a latent axis of resistance and tumor evolution in HER2-targeted therapy

Madhan Krishnan, Shyamaladevi Babu

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217998 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cancer Letters, 2025. Verfasst von Madhan Krishnan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamilnadu, India. E…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Erb-b2 Receptor Tyrosine Kinases, Polyploidy, Giant Cells. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent findings by Yazdi et al. in Cancer Letters present a mechanistic breakthrough in understanding resistance to HER2-targeting antibody-drug conjugates (ADCs). Their identification of drug-persistent polyploid giant cancer cells (PGCCs) as active participants in resistance redefines our understanding of intratumoral plasticity and therapeutic evasion. Far from being senescent relics, PGCCs function as epigenetically plastic reservoirs of tumor regeneration, capable of entering dormancy and re-seeding therapy-resistant clones. This commentary explores the mechanistic, evolutionary, and clinical implications of this phenomenon, urging a shift toward integrated therapeutic designs that disrupt the adaptive survival circuitry of PGCCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmErb-b2 Receptor Tyrosine KinasesPolyploidyGiant CellsNeoplasmsHumansMolecular Targeted TherapyImmunoconjugates

Stichwörter der Autor:innen

Adaptive therapyDormancyHER2-ADC resistanceNeosisPhenotypic plasticityPolyploid giant cancer cellsTumor evolution

Substanzen

Erb-b2 Receptor Tyrosine KinasesImmunoconjugatesERBB2 protein, human

Autor:innen und Institutionen

  • Faculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamilnadu, India. Electronic address: drmadhan@care.edu.in.
  • Faculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamilnadu, India.

Zitieren

APA

Krishnan, M., & Babu, S. (2025). Polyploid giant cancer cells: Unveiling a latent axis of resistance and tumor evolution in HER2-targeted therapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217998

Vancouver

Krishnan M, Babu S. Polyploid giant cancer cells: Unveiling a latent axis of resistance and tumor evolution in HER2-targeted therapy. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217998

BibTeX
@article{Krishnan2025,
  author = {Krishnan, Madhan and Babu, Shyamaladevi},
  title = {Polyploid giant cancer cells: Unveiling a latent axis of resistance and tumor evolution in HER2-targeted therapy},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217998}
}
Kostenlos starten →